Persistent Asset Partners Ltd

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Persistent Asset Partners Ltd reported 96 stock positions worth $116.7 million. Its top holding was Humana (HUM) at 9.6% of the portfolio, followed by Davita (DVA, 6.5%) and Unitedhealth (UNH, 5.5%).

Most Recent 13F
Q2 2026
Location
HONG KONG, K3
CIK
0002056052
Portfolio Value
$116.7M (Q4 2024)
SEC Filing
0001104659-25-014059 ↗ filed Feb 14, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q4 2024: $116.7M $116.7M Q4 2024 Q1 2025: $113.3M Q1 2025 Q2 2025: $114.1M Q2 2025 Q3 2025: $138.1M Q3 2025 Q4 2025: $208.0M Q4 2025 Q1 2026: $257.4M Q1 2026 Q2 2026: $316.9M Q2 2026

Holdings 96 stocks · $116.7M

HUM Humana Inc. 9.58% 38,160 $11.2M —
DVA Davita Inc. 6.51% 43,148 $7.6M —
UNH Unitedhealth Group Inc. 5.49% 11,824 $6.4M —
PNTG The Pennant Group Inc. 3.74% 164,992 $4.4M —
CAH Cardinal Health Inc. 3.58% 33,798 $4.2M —
BTSG Brightspring Health Services 3.46% 171,064 $4.0M —
ALHC Alignment Healthcare Inc. 3.22% 244,154 $3.8M —
WBA Walgreens Boots Alliance Inc. 3.01% 341,366 $3.5M —
CNC Centene Corp. 2.44% 44,545 $2.9M —
ACHC Acadia Healthcare Co. Inc. 2.34% 60,455 $2.7M —
EHAB Enhabit Inc. 2.14% 297,123 $2.5M —
FCNCA First Citizens Bcshs Class A 1.88% 994 $2.2M —
CVS CVS Health Corp. 1.87% 38,697 $2.2M —
MCK McKesson Corp. 1.75% 3,433 $2.0M —
C Citigroup Inc. 1.73% 24,853 $2.0M —
DFS Discover Financial Services 1.61% 9,320 $1.9M —
BMRN Biomarin Pharmaceutical Inc. 1.46% 26,856 $1.7M —
PCVX Vaxcyte Inc. 1.45% 19,151 $1.7M —
CCB Coastal Financial Corp. 1.42% 18,641 $1.7M —
CNOB Connectone Bancorp Inc. 1.42% 65,235 $1.7M —
NBIX Neurocrine Biosciences Inc. 1.40% 10,744 $1.6M —
NXE Nexgen Energy Ltd. 1.31% 234,030 $1.5M —
FISI Financial Institutions Inc. 1.28% 56,715 $1.5M —
EHTH Ehealth Inc. 1.28% 150,035 $1.5M —
MRK Merck & Co. Inc. 1.14% 13,422 $1.3M —
OSBC Old Second Bancorp Inc. 1.10% 68,343 $1.3M —
QCRH QCR Holdings Inc. 1.03% 15,532 $1.2M —
GS Goldman Sachs Group Inc. 1.02% 1,864 $1.2M —
LLY Eli Lilly & Co. 1.02% 1,468 $1.2M —
ASND Ascendis Pharma A/S 1.00% 8,940 $1.2M —
SLNO Soleno Therapeutics Inc. 0.94% 21,809 $1.1M —
BPMC Blueprint Medicines Corp. 0.93% 9,693 $1.1M —
RYTM Rhythm Pharmaceuticals Inc. 0.93% 18,312 $1.1M —
HOOD Robinhood Markets Inc. Class A 0.90% 20,315 $1.1M —
SOFI Sofi Technologies Inc. 0.87% 64,600 $1.0M —
WFC Wells Fargo & Co. 0.84% 12,428 $979K —
EGO Eldorado Gold Corp. 0.84% 64,120 $977K —
INSM Insmed Inc. 0.82% 12,500 $957K —
FHN First Horizon Corp. 0.82% 43,492 $952K —
EQBK Equity Bancshares Inc. Class A 0.81% 21,746 $948K —
CASH Pathward Financial Inc. 0.72% 10,558 $842K —
TARS Tarsus Pharmaceuticals Inc. 0.71% 15,477 $832K —
CVE Cenovus Energy Inc. 0.71% 57,041 $825K —
IBOC International Bancshares CRP 0.70% 12,425 $819K —
HBM Hudbay Minerals Inc. 0.65% 92,022 $758K —
APGE Apogee Therapeutics Inc. 0.64% 17,940 $742K —
GPK Graphic Packaging Holding Co. 0.61% 26,147 $717K —
LNWO Light & Wonder Inc. 0.61% 7,941 $710K —
TGTX TG Therapeutics Inc. 0.61% 22,366 $709K —
SSB Southstate Bank Corp. 0.56% 6,210 $656K —
RLAY Relay Therapeutics Inc. 0.56% 145,828 $652K —
RCUS Arcus Biosciences Inc. 0.55% 50,213 $648K —
CNTA Centessa Pharmaceuticals Ltd. 0.55% 37,701 $638K —
COGT Cogent Biosciences Inc. 0.54% 67,617 $630K —
COOP Mr Cooper Group Inc. 0.50% 5,593 $581K —
CRNX Crinetics Pharmaceuticals Inc. 0.46% 13,184 $531K —
SRRK Scholar Rock Holding Corp. 0.45% 13,103 $529K —
SMBK Smartfinancial Inc. 0.45% 14,912 $526K —
CVBF CVB Financial Corp. 0.44% 24,853 $518K —
KWEB Kranesh Csi China Internet 0.44% 16,440 $514K —
VRDN Viridian Therapeutics Inc. 0.42% 25,237 $489K —
VBNK Versabank 0.41% 34,178 $473K —
EWTX Edgewise Therapeutics Inc. 0.40% 16,593 $465K —
TOWN Towne Bank 0.38% 12,426 $444K —
SYF Synchrony Financial 0.37% 6,214 $429K —
REPL Replimune Group Inc. 0.35% 29,103 $407K —
SAGE Sage Therapeutics Inc. 0.33% 53,721 $389K —
EWBC East West Bancorp Inc. 0.33% 3,727 $384K —
NUVL Nuvalent Inc. Class A 0.33% 4,435 $381K —
UWMC Uwm Holdings Corp. 0.32% 62,131 $375K —
WBS Webster Financial Corp. 0.32% 6,211 $374K —
KALV Kalvista Pharmaceuticals Inc. 0.32% 41,952 $374K —
PFE Pfizer Inc. 0.31% 13,530 $359K —
VTGN Vistagen Therapeutics Inc. 0.30% 121,651 $352K —
FFBC First Financial Bancorp 0.30% 12,422 $348K —
EQX Equinox Gold Corp. 0.30% 57,072 $346K —
MYFW First Western Financial Inc. 0.26% 14,538 $307K —
REVIVA PHARMACEUTCLS HLDGS I 0.26% 161,170 $305K —
ARQT Arcutis Biotherapeutics Inc. 0.26% 22,810 $302K —
CLYM Climb Bio Inc. 0.24% 145,760 $277K —
EOLS Evolus Inc. 0.23% 19,054 $266K —
ETNB 89BIO Inc. 0.22% 26,842 $258K —
VIR Vir Biotechnology Inc. 0.21% 24,069 $250K —
ESQ Esquire Financial Holdings I 0.21% 2,797 $250K —
RKT Rocket Cos Inc. Class A 0.13% 12,426 $157K —
NKTR Nektar Therapeutics 0.12% 166,572 $138K —
SLSR Solaris Resources Inc. 0.11% 41,812 $134K —
ZVRA Zevra Therapeutics Inc. 0.09% 12,831 $101K —
ORIC Oric Pharmaceuticals Inc. 0.07% 7,373 $77K —
ELDN Eledon Pharmaceuticals Inc. 0.06% 14,855 $67K —
GOSS Gossamer Bio Inc. 0.06% 65,894 $65K —
TERN Terns Pharmaceuticals Inc. 0.05% 12,807 $57K —
CADL Candel Therapeutics Inc. 0.04% 6,046 $43K —
MODVQ Modivcare Inc. 0.03% 8,757 $35K —
CMRX Chimerix Inc. 0.03% 8,813 $35K —
QTTB Q32 Bio Inc. 0.02% 6,019 $18K —

Options reported separately and not counted above: KROS puts ($360K), QTTB puts ($344K), SLNO calls ($329K), BBIO calls ($260K), HALO calls ($238K), SPY puts ($225K), RARE puts ($174K), RXRX calls ($168K), KRE calls ($150K), AGIO calls ($133K), SLNO puts ($130K), CAPR calls ($115K), and 35 more.

Portfolio Sells Q4 2024

No earlier filing to compare with.

Portfolio Buys Q4 2024

No earlier filing to compare with.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 713$316.9MINTC, HOOD, STM, APH, STX
Q1 2026 238$257.4MLITE, AXTI, INTC, TSEM, SNDK
Q4 2025 275$208.0MCNC, MOH, ELV, INTC, AXTI
Q3 2025Amended 149$138.1MCNC, IEF, UNH, REGN, CVS
Q2 2025 116$114.1MIBIT, SLNO, HUM, PNTG, EHC
Q1 2025 110$113.3MCNC, IBIT, ALHC, UNH, REGN
Q4 2024 96$116.7MHUM, DVA, UNH, PNTG, CAH